Robotically repairing ventral or inguinal hernias using OviTex mesh
Official title: A Prospective Study Evaluating the Clinical Outcomes of Ventral or Inguinal Hernias Treated Robotically With OviTex® Reinforced Tissue Matrix
Run by Tela Bio Inc · NCT04779918 · Data updated 2026-11-12
This study is testing whether using a special mesh called OviTex in robotic surgery can help people with ventral or inguinal hernias recover better and avoid complications.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 21 Years and up |
| Sex | All |
| Enrollment | 160 (estimated) |
| Sponsor | Tela Bio Inc Industry-sponsored |
| Locations | 10 sites (Mobile, Alabama and 9 other locations) |
| Status | Recruiting |
| Started | April 29, 2021 |
| Main results expected | March 30, 2027 |
| Study ends | December 30, 2029 |
| Registry record updated | May 5, 2026 |
| Trial ID | NCT04779918 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 21 and older with ventral or inguinal hernias requiring surgical repair using an implant.
✕Probably not a fit
Patients with hernias that do not require surgical repair or those with contraindications for robotic surgery may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the post-operative complications and recurrence rates of ventral or inguinal hernias treated with OviTex mesh using a robotic surgical approach. Up to 160 participants will be enrolled across 20 sites, all receiving the OviTex Reinforced Tissue Matrix for their hernia repair. The study aims to gather data on the effectiveness and safety of this specific mesh in robotic surgeries.
Why it matters
Potential benefit: If successful, this study could lead to improved surgical outcomes and reduced recurrence rates for patients undergoing hernia repair.
How similar studies have gone: Other studies have shown promising results with robotic hernia repairs, but the specific use of OviTex mesh in this context is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Subject suffers from a ventral or inguinal hernia that requires surgical repair with the use of an implant to reinforce or replace weakened or missing tissue. 2. The patient is scheduled for an elective robotic approach with the use of OviTex LPR, OviTex Core Permanent, OviTex 1S Permanent, or OviTex IHR. 3. The size of the implant needed for repair is expected to be less than or equal to 15 x 25 cm for OviTex LPR and 25 x 40 cm for OviTex Core Permanent and OviTex 1S Permanent, with no size limitation for OviTex IHR. 4. Subject meets CDC/SSI Wound Classification Class I (Clean), Class II (Clean-Contaminated) or Class III (Contaminated) criteria. 5. Subject is willing and able to sign an informed consent for the study and has signed the IRB approved Informed Consent form for this study. 6. Subject is able to complete Quality of Life (QoL) and pain questionnaires. 7. Subject is at least 21 years old. 8. Subject is willing to comply and able to participate fully in, and for the full duration of, the study including follow-up requirements. Exclusion Criteria at Baseline: 1. Subject has a BMI of \> 40 2. Subject meets CDC/SSI Wound Classification Class IV (Dirty-Infected) criteria 3. Subject is female and is pregnant or plans to become pregnant during the course of the study. 4. Subject has a life expectancy of \< 2 years making it unlikely that the subject will successfully achieve two-year follow-up. 5. Subject has recent history of drug or alcohol abuse (in last 3 years). 6. Subject has an allergy to ovine-derived products. 7. Subject has participated in another clinical trial within the past 30 days or is currently involved in another clinical trial. 8. Subject has a strangulated hernia. Exclusion Criteria Intraoperative: 1. Subject requires implant that cannot be introduced into the surgical site during the procedure via port or an existing incision. 2. Subject unable to receive OviTex LPR, OviTex Core Permanent, OviTex 1S Permanent, or OviTex IHR at time of surgery.
Where it's running
-
University of South Alabama
Mobile, Alabama, United States Recruiting -
University of Louisville
Louisville, Kentucky, United States Recruiting -
Munson Healthcare
Traverse City, Michigan, United States Recruiting -
SurgOne
Denver, Colorado, United States Active not recruiting -
GenesisCare
Destin, Florida, United States Terminated -
Surgical Healing Arts Center
Fort Myers, Florida, United States Terminated
Show 4 more locations
-
St. Luke's Hospital
Overland Park, Kansas, United States Active not recruiting -
St. Francis Hospital
Roslyn, New York, United States Withdrawn -
Mohawk Valley Health System
Utica, New York, United States Withdrawn -
Houston Methodist
Houston, Texas, United States Active not recruiting
Study contacts
- Principal investigator: Geoffrey Slayden, MD — St. Lukes Hospital
- Study coordinator: Melissa LaMantia
- Email: mlamantia@telabio.com
- Phone: 757-761-4922
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Pneumoperitoneum time and bicarbonate changes during laparoscopic inguinal hernia repair
This study will see if longer pneumoperitoneum time during laparoscopic inguinal hernia repair causes changes in blood bicarbonate levels in adults.
-
Quadro-iliac plane block versus TAP block for pain after inguinal hernia surgery
In adults undergoing unilateral inguinal hernia repair, this study tests whether the Quadro-iliac Plane Block provides better postoperative pain relief than the Transversus Abdominis Plane Block.
-
Compliance-guided Closure Strategy for Large Ventral Hernia Repair
This study tests whether using a structured intraoperative plan based on respiratory system stiffness helps decide how to close the abdominal wall in people with large ventral hernias.
-
Pre‑surgery optimisation for ventral hernia repair
This trial tests whether a structured pre-surgery programme to boost activity, encourage weight loss, and optimise other health problems helps adults with 4–8 cm ventral hernias have fewer complications after surgery.
-
Comparing mesh removal to no mesh removal for chronic groin pain after hernia repair
This study is testing whether taking out hernia mesh helps people with chronic groin pain feel better compared to not removing the mesh after their hernia repair.
-
Evaluation of GORE® ENFORM Biomaterial for Hernia Repair
This study is testing a new material for hernia repair to see how well it works and how patients feel about it after surgery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.